Farms.com Home   News

FDA Extends Educational Period for New Policy on Compounding Animal Drugs from Bulk Drug Substances

The Food and Drug Administration has delayed enforcement of its finalized guidance regarding compounding animal drugs from bulk drug substances until April 2023.

The Food and Drug Administration issued final guidance, unveiled in April, on the use of bulk drug substances for compounding animal medications. Under Guidance for Industry #256, Compounding Animal Drugs from Bulk Drug Substances, the FDA delineates the circumstances under which it will exercise enforcement discretion related to violations of the Federal Food, Drug, and Cosmetic Act for drug approval, labeling, and manufacturing when pharmacists and veterinarians compound drugs from bulk drug substances for animal patients.

Click here to see more...

Trending Video

What Successful AI Implementation Looks Like in the Protein Industry | Ben Allen, CEO of BinSentry

Video: What Successful AI Implementation Looks Like in the Protein Industry | Ben Allen, CEO of BinSentry

In this conversation, Ben Allen, CEO of BinSentry, explores what separates successful AI implementation from early experimentation across the protein industry. As producers begin integrating artificial intelligence into their operations, the most effective implementations share common themes: strong data foundations, practical use cases, and a focus on solving real operational challenges. Ben discusses why data quality and integration are essential for AI to deliver meaningful results, and why technology alone is not enough. Successful adoption also depends heavily on people, training, and company culture, ensuring teams understand how to use new tools and trust the insights they provide. Looking ahead, the conversation highlights the steps protein producers can take today—from improving data infrastructure to embracing digital tools—to position their operations for long-term success in an increasingly AI-driven industry.